Journal of Antibiotics
Leading citation impact metric from Clarivate Journal Citation Reports
73 papers with at least that number of citations each
State Council for Professorship (HĐGSNN) Scoring
Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)
HĐGSNN Score History
By article publication year| Year | Max Score | Evaluation Details | Source |
|---|---|---|---|
| 2026 | 1.50đ | WoS Q3(IF: 2.7) | 🔵 Computed |
| 2025 | 1.50đ | WoS Q3(IF: 2.7) | 🔵 Computed |
| 2024 | 1.50đ | WoS Q3(IF: 2.1) | 🔵 Computed |
| 2023 | 1.50đ | WoS Q3(IF: 3.3) | 🔵 Computed |
| 2022 | 1.50đ | WoS Q3(IF: 3.424) | 🔵 Computed |
| 2021 | 1.50đ | WoS Q3(IF: 2.649) | 🔵 Computed |
| 2020 | 1.50đ | WoS Q3(IF: 2.668) | 🔵 Computed |
| 2019 | 1.50đ | WoS Q3(IF: 2.446) | 🔵 Computed |
| 2018 | 1.50đ | WoS Q3(IF: 2.033) | 🔵 Computed |
Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.
Aims & Scope
The Journal of Antibiotics seeks to promote research on antibiotics and related types of biologically active substances and publishes Articles, Review Articles, Brief Communication, Correspondence and other specially commissioned reports. The Journal of Antibiotics accepts papers on biochemical, chemical, microbiological and pharmacological studies. However, studies regarding human therapy do not fall under the journal’s scope. Contributions regarding recently discovered antibiotics and biologically active microbial products are particularly encouraged. Topics of particular interest within the journal's scope include, but are not limited to, those listed below: Discovery of new antibiotics and related types of biologically active substances Production, isolation, characterization, structural elucidation, chemical synthesis and derivatization, biological activities, mechanisms of action, and structure-activity relationships of antibiotics and related types of biologically active substances Biosynthesis, bioconversion, taxonomy and genetic studies on producing microorganisms, as well as improvement of production of antibiotics and related types of biologically active substances Novel physical, chemical, biochemical, microbiological or pharmacological methods for detection, assay, determination, structural elucidation and evaluation of antibiotics and related types of biologically active substances Newly found properties, mechanisms of action and resistance-development of antibiotics and related types of biologically active substances.
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Measures cumulative publication volume and citation impact.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
| Category | Index | Rank | Quartile |
|---|---|---|---|
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | JCRSCIE | 112/180 | Q3 |
IMMUNOLOGY | JCRSCIE | 124/183 | Q3 |
MICROBIOLOGY | JCRSCIE | 110/167 | Q3 |
PHARMACOLOGY & PHARMACY | JCRSCIE | 191/356 | Q3 |
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | JCISCIE | 105/180 | Q3 |
IMMUNOLOGY | JCISCIE | 116/183 | Q3 |
MICROBIOLOGY | JCISCIE | 107/167 | Q3 |
PHARMACOLOGY & PHARMACY | JCISCIE | 206/356 | Q3 |
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
| Year | Impact Factor | Articles / Year | Total Citations |
|---|---|---|---|
| 2026 | — | 69 | 15 |
| 2025 | 2.7 | 89 | 141 |
| 2024 | 2.1 | 108 | 452 |
| 2023 | 3.3 | 98 | 971 |
| 2022 | 3.424 | 93 | 778 |
| 2021 | 2.649 | 102 | 1,374 |
| 2020 | 2.668 | 128 | 3,223 |
| 2019 | 2.446 | 136 | 2,591 |
| 2018 | 2.033 | 143 | 2,461 |
| 2017 | — | 172 | 4,901 |
| 2016 | — | 168 | 4,003 |
| 2015 | — | 139 | 3,116 |
Journal Metrics & Citation Visualizations
Impact Factor Trend (2018–2024)
Clarivate IF trend for Journal of Antibiotics
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics